Prellis is dedicated to building tissues to eliminate the organ transplant waitlist.

Our mission is to use novel tissue engineering technology to advance human health.

Human tissue engineering is a complex problem. Why will Prellis succeed?


The advent of bioprinting was an exciting moment for the emerging field of tissue engineering. For the first time, cells could be extruded into different shapes and patterns with extreme accuracy and higher resolution than ever before. However, it quickly became apparent that extrusion printing would not build large transplantable organs or tissues.

At the core of the technology was an engineering problem: No bioprinting technology had the speed and the resolution necessary to build biomimetic tissues below a 100 micrometer feature size.

Capillaries, 10-20 microns in diameter, are the blood vessels where oxygen and nutrient exchange is facilitated in every living tissue. Without capillary perfusion, tissues quickly begin to die.

Prellis has solved this engineering problem by using ultra-fast laser printing to create bioprinted feature sizes and shapes that match the fine vasculature of tissues and organs.

By generating freeform biocompatible, biodegradable, nutrient and oxygen permeable scaffolds living vascularized tissues can be created in the laboratory setting.





What distinguishes Prellis from other tissue engineering companies?


By combining expertise in the Chemistry, Optical Engineering, Microfluidics, Cell Biology, and Software development spaces, Prellis has developed a full-stack process and platform for end-to-end tissue development starting with high-resolution 3D design engineering and ending with bioreactor-based tissue maturation.
Prellis is already answering questions that other tissue engineering endeavors have yet to answer around basic capillary flow network design and engineering for organ compatibility. Our process is an end-to-end approach that produces ultrafast tissue scaffolds.





prellis-white-icon-01.png
prellis-white-icon-01.png

What distinguishes Prellis from other tissue engineering companies?


By combining expertise in the Chemistry, Optical Engineering, Microfluidics, Cell Biology, and Software development spaces, Prellis has developed a full-stack process and platform for end-to-end tissue development starting with high-resolution 3D design engineering and ending with bioreactor-based tissue maturation.
Prellis is already answering questions that other tissue engineering endeavors have yet to answer around basic capillary flow network design and engineering for organ compatibility. Our process is an end-to-end approach that produces ultrafast tissue scaffolds.





What distinguishes Prellis from other tissue engineering companies?


By combining expertise in the Chemistry, Optical Engineering, Microfluidics, Cell Biology, and Software development spaces, Prellis has developed a full-stack process and platform for end-to-end tissue development starting with high-resolution 3D design engineering and ending with bioreactor-based tissue maturation.
Prellis is already answering questions that other tissue engineering endeavors have yet to answer around basic capillary flow network design and engineering for organ compatibility. Our process is an end-to-end approach that produces ultrafast tissue scaffolds.





Human tissue engineering is a complex problem. Why will Prellis succeed?


The advent of bioprinting was an exciting moment for the emerging field of tissue engineering. For the first time, cells could be extruded into different shapes and patterns with extreme accuracy and higher resolution than ever before. However, it quickly became apparent that extrusion printing would not build large transplantable organs or tissues.

At the core of the technology was an engineering problem: No bioprinting technology had the speed and the resolution necessary to build biomimetic tissues below a 100 micrometer feature size.

Capillaries, 10-20 microns in diameter, are the blood vessels where oxygen and nutrient exchange is facilitated in every living tissue. Without capillary perfusion, tissues quickly begin to die.

Prellis has solved this engineering problem by using ultra-fast laser printing to create bioprinted feature sizes and shapes that match the fine vasculature of tissues and organs.

By generating freeform biocompatible, biodegradable, nutrient and oxygen permeable scaffolds living vascularized tissues can be created in the laboratory setting.





prellis-white-icon-01.png

What distinguishes Prellis from other tissue engineering companies?


By combining expertise in the Chemistry, Optical Engineering, Microfluidics, Cell Biology, and Software development spaces, Prellis has developed a full-stack process and platform for end-to-end tissue development starting with high-resolution 3D design engineering and ending with bioreactor-based tissue maturation.
Prellis is already answering questions that other tissue engineering endeavors have yet to answer around basic capillary flow network design and engineering for organ compatibility. Our process is an end-to-end approach that produces ultrafast tissue scaffolds.





prellis-white-icon-01.png
prellis-white-icon-01.png
prellis-white-icon-01.png

What distinguishes Prellis from other tissue engineering companies?


By combining expertise in the Chemistry, Optical Engineering, Microfluidics, Cell Biology, and Software development spaces, Prellis has developed a full-stack process and platform for end-to-end tissue development starting with high-resolution 3D design engineering and ending with bioreactor-based tissue maturation.
Prellis is already answering questions that other tissue engineering endeavors have yet to answer around basic capillary flow network design and engineering for organ compatibility. Our process is an end-to-end approach that produces ultrafast tissue scaffolds.





prellis-white-icon-01.png
_kidney_rotate-min.gif